<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36930682</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>PLoS biology</Title><ISOAbbreviation>PLoS Biol</ISOAbbreviation></Journal><ArticleTitle>TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A.</ArticleTitle><Pagination><StartPage>e3002028</StartPage><MedlinePgn>e3002028</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3002028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.3002028</ELocationID><Abstract><AbstractText>A major function of TAR DNA-binding protein-43 (TDP-43) is to repress the inclusion of cryptic exons during RNA splicing. One of these cryptic exons is in UNC13A, a genetic risk factor for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The accumulation of cryptic UNC13A in disease is heightened by the presence of a risk haplotype located within the cryptic exon itself. Here, we revealed that TDP-43 extreme N-terminus is important to repress UNC13A cryptic exon inclusion. Further, we found hnRNP L, hnRNP A1, and hnRNP A2B1 bind UNC13A RNA and repress cryptic exon inclusion, independently of TDP-43. Finally, higher levels of hnRNP L protein associate with lower burden of UNC13A cryptic RNA in ALS/FTD brains. Our findings suggest that while TDP-43 is the main repressor of UNC13A cryptic exon inclusion, other hnRNPs contribute to its regulation and may potentially function as disease modifiers.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickles</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estades Ayuso</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen-West</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Yue A</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Center for Alzheimer's and Related Dementias, National Institute on Aging, NIH, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ziyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Alzheimer's and Related Dementias, National Institute on Aging, NIH, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daughrity</LastName><ForeName>Lillian M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong-Jie</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickson</LastName><ForeName>Dennis W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Alzheimer's and Related Dementias, National Institute on Aging, NIH, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrucelli</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2959-129X</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudencio</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4894-4858</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 NS097273</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG063780</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS084974</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS123743</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS120992</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS117461</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034664">Heterogeneous-Nuclear Ribonucleoprotein L</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034441">Heterogeneous-Nuclear Ribonucleoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS Biol. 2023 Jul 14;21(7):e3002228</RefSource><PMID Version="1">37451236</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034664" MajorTopicYN="Y">Heterogeneous-Nuclear Ribonucleoprotein L</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034441" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: LP serves as a Consultant for Expansion Therapeutics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36930682</ArticleId><ArticleId IdType="pmc">PMC10057836</ArticleId><ArticleId IdType="doi">10.1371/journal.pbio.3002028</ArticleId><ArticleId IdType="pii">PBIOLOGY-D-22-01714</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. Epub 2016/11/11. doi: 10.1038/nature20413 ; PubMed Central PMCID: PMC5585017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;38. Epub 2013/08/13. doi: 10.1016/j.neuron.2013.07.033 ; PubMed Central PMCID: PMC4411085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010;19(R1):R46&#x2013;R64. Epub 2010/04/20. doi: 10.1093/hmg/ddq137 [pii] ; PubMed Central PMCID: PMC3167692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al.. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011. Epub 2011/03/02. doi: 10.1038/nn.2779 [pii] .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, et al.. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14(4):452&#x2013;8. Epub 2011/03/02. doi: 10.1038/nn.2778 ; PubMed Central PMCID: PMC3108889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Bampton A, Gittings LM, Fratta P, Lashley T, Gatt A. The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol. 2020;140(5):599&#x2013;623. Epub 2020/08/05. doi: 10.1007/s00401-020-02203-0 ; PubMed Central PMCID: PMC7547044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02203-0</ArticleId><ArticleId IdType="pmc">PMC7547044</ArticleId><ArticleId IdType="pubmed">32748079</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9(2):1104&#x2013;20. Epub 2009/12/22. doi: 10.1021/pr901076y ; PubMed Central PMCID: PMC2897173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349(6248):650&#x2013;655. doi: 10.1126/science.aab0983 ; PubMed Central PMCID: PMC4825810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q, Yalamanchili HK, Park J, De Maio A, Lu HC, Wan YW, et al.. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum Mol Genet. 2016;25(23):5083&#x2013;93. Epub 2016/12/23. doi: 10.1093/hmg/ddw337 ; PubMed Central PMCID: PMC5968355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw337</ArticleId><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A, Sun M, Ling JP, Braunstein KE, Pang B, Wen X, et al.. Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathol. 2019;138(5):813&#x2013;26. Epub 2019/07/25. doi: 10.1007/s00401-019-02042-8 ; PubMed Central PMCID: PMC6802294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02042-8</ArticleId><ArticleId IdType="pmc">PMC6802294</ArticleId><ArticleId IdType="pubmed">31332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Bell W, LaClair KD, Ling JP, Han H, Kageyama Y, et al.. Cryptic exon incorporation occurs in Alzheimer&#x2019;s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. Acta Neuropathol. 2017;133(6):923&#x2013;931. doi: 10.1007/s00401-017-1701-2 ; PubMed Central PMCID: PMC5444385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1701-2</ArticleId><ArticleId IdType="pmc">PMC5444385</ArticleId><ArticleId IdType="pubmed">28332094</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong YH, Ling JP, Lin SZ, Donde AN, Braunstein KE, Majounie E, et al.. Tdp-43 cryptic exons are highly variable between cell types. Mol Neurodegener. 2017;12(1):13. doi: 10.1186/s13024-016-0144-x ; PubMed Central PMCID: PMC5289002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0144-x</ArticleId><ArticleId IdType="pmc">PMC5289002</ArticleId><ArticleId IdType="pubmed">28153034</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Emmett W, Fratta P, Isaacs AM, Plagnol V. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med Genomics. 2017;10(1):38. doi: 10.1186/s12920-017-0274-1 ; PubMed Central PMCID: PMC5446763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-017-0274-1</ArticleId><ArticleId IdType="pmc">PMC5446763</ArticleId><ArticleId IdType="pubmed">28549443</ArticleId></ArticleIdList></Reference><Reference><Citation>McClory SP, Lynch KW, Ling JP. HnRNP L represses cryptic exons. RNA. 2018;24(6):761&#x2013;8. Epub 2018/03/28. doi: 10.1261/rna.065508.117 ; PubMed Central PMCID: PMC5959245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.065508.117</ArticleId><ArticleId IdType="pmc">PMC5959245</ArticleId><ArticleId IdType="pubmed">29581412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Chhabra R, Merran JD, Schaughency PM, Wheelan SJ, Corden JL, et al.. PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons. Cell Rep. 2016;17(1):104&#x2013;13. Epub 2016/09/30. doi: 10.1016/j.celrep.2016.08.071 ; PubMed Central PMCID: PMC5082185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.071</ArticleId><ArticleId IdType="pmc">PMC5082185</ArticleId><ArticleId IdType="pubmed">27681424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bampton A, Gatt A, Humphrey J, Cappelli S, Bhattacharya D, Foti S, et al.. HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing. Acta Neuropathol. 2021;142(4):609&#x2013;27. Epub 2021/07/19. doi: 10.1007/s00401-021-02340-0 ; PubMed Central PMCID: PMC8423707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02340-0</ArticleId><ArticleId IdType="pmc">PMC8423707</ArticleId><ArticleId IdType="pubmed">34274995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohagheghi F, Prudencio M, Stuani C, Cook C, Jansen-West K, Dickson DW, et al.. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Hum Mol Genet. 2016;25(3):534&#x2013;45. Epub 2015/11/29. doi: 10.1093/hmg/ddv491 ; PubMed Central PMCID: PMC4731020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv491</ArticleId><ArticleId IdType="pmc">PMC4731020</ArticleId><ArticleId IdType="pubmed">26614389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarnack K, Konig J, Tajnik M, Martincorena I, Eustermann S, Stevant I, et al.. Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of Alu elements. Cell. 2013;152(3):453&#x2013;66. Epub 2013/02/05. doi: 10.1016/j.cell.2012.12.023 ; PubMed Central PMCID: PMC3629564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.12.023</ArticleId><ArticleId IdType="pmc">PMC3629564</ArticleId><ArticleId IdType="pubmed">23374342</ArticleId></ArticleIdList></Reference><Reference><Citation>West KO, Scott HM, Torres-Odio S, West AP, Patrick KL, Watson RO. The Splicing Factor hnRNP M Is a Critical Regulator of Innate Immune Gene Expression in Macrophages. Cell Rep. 2019;29(6):1594&#x2013;609 e5. Epub 2019/11/07. doi: 10.1016/j.celrep.2019.09.078 ; PubMed Central PMCID: PMC6981299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.078</ArticleId><ArticleId IdType="pmc">PMC6981299</ArticleId><ArticleId IdType="pubmed">31693898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al.. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603(7899):124&#x2013;30. Epub 2022/02/25. doi: 10.1038/s41586-022-04424-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, et al.. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603(7899):131&#x2013;7. Epub 2022/02/25. doi: 10.1038/s41586-022-04436-3 ; PubMed Central PMCID: PMC8891020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipstein N, Verhoeven-Duif NM, Michelassi FE, Calloway N, van Hasselt PM, Pienkowska K, et al.. Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. J Clin Invest. 2017;127(3):1005&#x2013;18. Epub 2017/02/14. doi: 10.1172/JCI90259 ; PubMed Central PMCID: PMC5330740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90259</ArticleId><ArticleId IdType="pmc">PMC5330740</ArticleId><ArticleId IdType="pubmed">28192369</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin I, Rosenmund C, Sudhof TC, Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature. 1999;400(6743):457&#x2013;61. Epub 1999/08/10. doi: 10.1038/22768 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/22768</ArticleId><ArticleId IdType="pubmed">10440375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohme MA, Beis C, Reddy-Alla S, Reynolds E, Mampell MM, Grasskamp AT, et al.. Active zone scaffolds differentially accumulate Unc13 isoforms to tune Ca(2+) channel-vesicle coupling. Nat Neurosci. 2016;19(10):1311&#x2013;20. Epub 2016/08/16. doi: 10.1038/nn.4364 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4364</ArticleId><ArticleId IdType="pubmed">27526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanarayana M, Liu H, Michelassi F, Li L, Betensky D, Dominguez MJ, et al.. A unique C2 domain at the C terminus of Munc13 promotes synaptic vesicle priming. Proc Natl Acad Sci U S A. 2021;118(11). Epub 2021/04/11. doi: 10.1073/pnas.2016276118 ; PubMed Central PMCID: PMC7980281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016276118</ArticleId><ArticleId IdType="pmc">PMC7980281</ArticleId><ArticleId IdType="pubmed">33836576</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, van Vught PW, van Rheenen W, Koppers M, Pasterkamp RJ, van Es MA, et al.. UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(3):630 e3&#x2013;8. Epub 2011/11/29. doi: 10.1016/j.neurobiolaging.2011.10.029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.029</ArticleId><ArticleId IdType="pubmed">22118904</ArticleId></ArticleIdList></Reference><Reference><Citation>Placek K, Baer GM, Elman L, McCluskey L, Hennessy L, Ferraro PM, et al.. UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2019;73:190&#x2013;9. Epub 2018/10/28. doi: 10.1016/j.neurobiolaging.2018.09.031 ; PubMed Central PMCID: PMC6251755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.031</ArticleId><ArticleId IdType="pmc">PMC6251755</ArticleId><ArticleId IdType="pubmed">30368160</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, et al.. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009;41(10):1083&#x2013;7. Epub 2009/09/08. doi: 10.1038/ng.442 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, et al.. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol. 2019;137(6):879&#x2013;99. Epub 2019/02/11. doi: 10.1007/s00401-019-01962-9 ; PubMed Central PMCID: PMC6533145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01962-9</ArticleId><ArticleId IdType="pmc">PMC6533145</ArticleId><ArticleId IdType="pubmed">30739198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal-Taboada JM, Lopez-Lopez A, Salvado M, Lorenzo L, Garcia C, Mahy N, et al.. UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort. J Neurol. 2015;262(10):2285&#x2013;92. Epub 2015/07/15. doi: 10.1007/s00415-015-7843-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7843-z</ArticleId><ArticleId IdType="pubmed">26162714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Jiang H, Wang F, Li S, Wu C, Bao J, et al.. UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis. Neurol Sci. 2019;40(11):2293&#x2013;302. Epub 2019/06/16. doi: 10.1007/s10072-019-03951-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03951-y</ArticleId><ArticleId IdType="pubmed">31201598</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak-Ferguson A, Ferguson SM. Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci Alliance. 2019;2(5). Epub 2019/09/19. doi: 10.26508/lsa.201900358 ; PubMed Central PMCID: PMC6749094.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900358</ArticleId><ArticleId IdType="pmc">PMC6749094</ArticleId><ArticleId IdType="pubmed">31527135</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001;276(39):36337&#x2013;36343. doi: 10.1074/jbc.M104236200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Caulfield T, Xu YF, Gendron TF, Hubbard J, Stetler C, et al.. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum Mol Genet. 2013;22(15):3112&#x2013;22. Epub 2013/04/12. doi: 10.1093/hmg/ddt166 ; PubMed Central PMCID: PMC3699067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt166</ArticleId><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN, et al.. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37(5). Epub 2018/02/14. doi: 10.15252/embj.201797452 ; PubMed Central PMCID: PMC5830921.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem. 2005;280(45):37572&#x2013;37584. doi: 10.1074/jbc.M505557200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505557200</ArticleId><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz I, Kosti I, Ares M Jr, Cline M, Mandel-Gutfreund Y. RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res. 2014;42(Web Server issue):W361&#x2013;7. Epub 2014/05/16. doi: 10.1093/nar/gku406 ; PubMed Central PMCID: PMC4086114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku406</ArticleId><ArticleId IdType="pmc">PMC4086114</ArticleId><ArticleId IdType="pubmed">24829458</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Kaeser PS, Xu W, Sudhof TC. RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13. Neuron. 2011;69(2):317&#x2013;31. Epub 2011/01/26. doi: 10.1016/j.neuron.2011.01.005 ; PubMed Central PMCID: PMC3063404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.01.005</ArticleId><ArticleId IdType="pmc">PMC3063404</ArticleId><ArticleId IdType="pubmed">21262469</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Shibagaki Y, Hattori S, Matsuoka M. Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Hum Mol Genet. 2015;24(6):1513&#x2013;27. Epub 2014/11/08. doi: 10.1093/hmg/ddu563 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu563</ArticleId><ArticleId IdType="pubmed">25378556</ArticleId></ArticleIdList></Reference><Reference><Citation>Appocher C, Mohagheghi F, Cappelli S, Stuani C, Romano M, Feiguin F, et al.. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 2017;45(13):8026&#x2013;45. Epub 2017/06/03. doi: 10.1093/nar/gkx477 ; PubMed Central PMCID: PMC5570092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx477</ArticleId><ArticleId IdType="pmc">PMC5570092</ArticleId><ArticleId IdType="pubmed">28575377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui J, Hung LH, Heiner M, Schreiner S, Neumuller N, Reither G, et al.. Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing. EMBO J. 2005;24(11):1988&#x2013;98. Epub 2005/05/13. doi: 10.1038/sj.emboj.7600677 ; PubMed Central PMCID: PMC1142610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600677</ArticleId><ArticleId IdType="pmc">PMC1142610</ArticleId><ArticleId IdType="pubmed">15889141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossbach O, Hung LH, Khrameeva E, Schreiner S, Konig J, Curk T, et al.. Crosslinking-immunoprecipitation (iCLIP) analysis reveals global regulatory roles of hnRNP L. RNA Biol. 2014;11(2):146&#x2013;55. Epub 2014/02/15. doi: 10.4161/rna.27991 ; PubMed Central PMCID: PMC3973733.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.27991</ArticleId><ArticleId IdType="pmc">PMC3973733</ArticleId><ArticleId IdType="pubmed">24526010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Wang Z, Hortobagyi T, Witten JT, Zarnack K, Kayikci M, et al.. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res. 2011;21(10):1572&#x2013;82. Epub 2011/08/19. doi: 10.1101/gr.122226.111 ; PubMed Central PMCID: PMC3202275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.122226.111</ArticleId><ArticleId IdType="pmc">PMC3202275</ArticleId><ArticleId IdType="pubmed">21846794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al.. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2013;73. Epub 2013/03/05. doi: 10.1038/nature11922 [pii]. ; PubMed Central PMCID: PMC3756911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez FJ, Pratt GA, Van Nostrand EL, Batra R, Huelga SC, Kapeli K, et al.. Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System. Neuron. 2016;92(4):780&#x2013;95. Epub 2016/10/25. doi: 10.1016/j.neuron.2016.09.050 ; PubMed Central PMCID: PMC5123850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.050</ArticleId><ArticleId IdType="pmc">PMC5123850</ArticleId><ArticleId IdType="pubmed">27773581</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrogio A, Buratti E, Stuani C, Guarnaccia C, Romano M, Ayala YM, et al.. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 2009;37(12):4116&#x2013;4126. Epub 2009/05/12. doi: 10.1093/nar/gkp342 [pii] ; PubMed Central PMCID: PMC2709582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp342</ArticleId><ArticleId IdType="pmc">PMC2709582</ArticleId><ArticleId IdType="pubmed">19429692</ArticleId></ArticleIdList></Reference><Reference><Citation>Britson KA, Ling JP, Braunstein KE, Montagne JM, Kastenschmidt JM, Wilson A, et al.. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Sci Transl Med. 2022;14(628):eabi9196. Epub 2022/01/20. doi: 10.1126/scitranslmed.abi9196 ; PubMed Central PMCID: PMC9118725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi9196</ArticleId><ArticleId IdType="pmc">PMC9118725</ArticleId><ArticleId IdType="pubmed">35044790</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo D, Ling JP, Molina-Castro GC, Langseth AJ, Waisman A, Nave KA, et al.. Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43. Elife. 2022;11. Epub 2022/03/22. doi: 10.7554/eLife.75230 ; PubMed Central PMCID: PMC8970587.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.75230</ArticleId><ArticleId IdType="pmc">PMC8970587</ArticleId><ArticleId IdType="pubmed">35311646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang KJ, Agrawal I, Vainshtein A, Ho WY, Xin W, Tucker-Kellogg G, et al.. TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells. Elife. 2021;10. Epub 2021/03/11. doi: 10.7554/eLife.64456 ; PubMed Central PMCID: PMC7946431.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64456</ArticleId><ArticleId IdType="pmc">PMC7946431</ArticleId><ArticleId IdType="pubmed">33689679</ArticleId></ArticleIdList></Reference><Reference><Citation>Susnjar U, Skrabar N, Brown AL, Abbassi Y, Phatnani H, Consortium NA, et al.. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease. Commun Biol. 2022;5(1):314. Epub 2022/04/07. doi: 10.1038/s42003-022-03253-8 ; PubMed Central PMCID: PMC8983780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03253-8</ArticleId><ArticleId IdType="pmc">PMC8983780</ArticleId><ArticleId IdType="pubmed">35383280</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies JE, Shkreta L, Moszczynski AJ, Sidibe H, Semmler S, Fouillen A, et al.. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain. 2018;141(5):1320&#x2013;33. Epub 2018/03/22. doi: 10.1093/brain/awy062 ; PubMed Central PMCID: PMC5917749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy062</ArticleId><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, et al.. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A. 2009;106(18):7607&#x2013;7612. Epub 2009/04/23. doi: 10.1073/pnas.0900688106 ; PubMed Central PMCID: PMC2671323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Jansen-West KR, Lee WC, Gendron TF, Zhang YJ, Xu YF, et al.. Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor. Proc Natl Acad Sci U S A. 2012;109(52):21510&#x2013;5. Epub 2012/12/14. doi: 10.1073/pnas.1211577110 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1211577110</ArticleId><ArticleId IdType="pmc">PMC3535614</ArticleId><ArticleId IdType="pubmed">23236149</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly L, Peng L, Lara E, Ramos D, Fernandopulle M, Pantazis CB, et al.. A fully automated FAIMS-DIA proteomic pipeline for high-throughput characterization of iPSC-derived neurons. 2021. doi: 10.1101/2021.11.24.469921</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.24.469921</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>